Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Not applicableStudy completedNCT02755233
What this trial is testing

Ipilimumab-induced Lung Toxicity: Observational Study

Who this might be right for
Metastatic Melanoma
University of Zurich 71
Testing effectiveness (Phase 2)WithdrawnNCT02400385
What this trial is testing

A Phase II Trial of Sunitinib and Nivolumab for KIT-mutated Advanced Melanoma

Who this might be right for
Melanoma
California Pacific Medical Center Research Institute
Early research (Phase 1)Study completedNCT00379132
What this trial is testing

131-I-TM-601 Study in Adults With Solid Tumors

Who this might be right for
Breast CancerNon-Small Cell Lung CancerMelanoma+5 more
TransMolecular 60
Early research (Phase 1)Study completedNCT02097875
What this trial is testing

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Who this might be right for
Skin Neoplasms
Blaze Bioscience Australia Pty Ltd 21
Testing effectiveness (Phase 2)Study completedNCT02366195
What this trial is testing

Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma

Who this might be right for
Unresected Stage IIIb to IVM1c Melanoma
Amgen 112
Early research (Phase 1)Looking for participantsNCT04903119
What this trial is testing

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

Who this might be right for
Metastatic MelanomaBRAF Gene Mutation
Rina Plattner 30
Not applicableEnded earlyNCT04106167
What this trial is testing

Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy

Who this might be right for
Advanced Solid TumorLymphomaGastric Cancer+15 more
Fate Therapeutics 20
Large-scale testing (Phase 3)UnknownNCT00811200
What this trial is testing

Treatment Of Radiation Retinopathy Trial

Who this might be right for
Uveal Melanoma
Leiden University Medical Center 220
Not applicableStudy completedNCT02975700
What this trial is testing

PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma

Who this might be right for
Melanoma
Daiichi Sankyo Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT02014441
What this trial is testing

Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene Laherparepvec

Who this might be right for
Melanoma
Amgen 61
Testing effectiveness (Phase 2)Study completedNCT00720031
What this trial is testing

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

Who this might be right for
Immunotherapy
Nantes University Hospital 16
Early research (Phase 1)Study completedNCT00516802
What this trial is testing

Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Who this might be right for
Melanoma Neoplasms
AstraZeneca 40
Early research (Phase 1)Study completedNCT00025181
What this trial is testing

Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 19
Large-scale testing (Phase 3)Study completedNCT01720407
What this trial is testing

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face

Who this might be right for
Lentigo Maligna Melanoma (Head or Neck)
Nantes University Hospital 259
Large-scale testing (Phase 3)Active Not RecruitingNCT05933577
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 1,089
Large-scale testing (Phase 3)Study completedNCT01667419
What this trial is testing

Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma

Who this might be right for
Melanoma
Hoffmann-La Roche 498
Testing effectiveness (Phase 2)Ended earlyNCT01160445
What this trial is testing

Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer

Who this might be right for
Metastatic MelanomaMetastatic Renal Cancer
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT02941900
What this trial is testing

Interest and Impact of Skin Cancer Genetic Testing

Who this might be right for
Non-melanoma Skin Cancer (NMSC)
Memorial Sloan Kettering Cancer Center 53
Next Page